<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02440997</url>
  </required_header>
  <id_info>
    <org_study_id>IRB # 15010015</org_study_id>
    <nct_id>NCT02440997</nct_id>
  </id_info>
  <brief_title>A Preliminary Investigation of the Efficacy of Aromatherapy in Reducing Discomfort in Youth With Chronic Headache</brief_title>
  <official_title>A Preliminary Investigation of the Efficacy of Aromatherapy in Reducing Discomfort in Youth With Chronic Headache</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Mercy Hospital Kansas City</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Mercy Hospital Kansas City</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to preliminarily establish the extent to which a brief
      aromatherapy intervention incrementally improves subjective and objective indicators of
      discomfort (pain, anxiety, and heart rate variability) beyond passive relaxation in youth
      with chronic headaches. A secondary objective is to establish the safety of using
      aromatherapy as a treatment strategy in youth with chronic headache. The investigators
      hypothesize that children randomized to the aromatherapy condition will demonstrate a greater
      improvement in pain, anxiety, and objectively measured distress (heart rate variability) than
      comparable children receiving only a passive relaxation treatment (a foot bath). The
      investigators further hypothesize that the aromatherapy intervention will be safe and
      well-tolerated by study participants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Complementary and alternative therapies play an increasing role in the multidisciplinary
      treatment of primary pediatric headache disorders. Every pediatric headache patient needs to
      have a personalized and tailored program of education, psychological strategies,
      pharmacotherapy and complementary medicine choices. This particular study may prove desirable
      for parents of children and adolescents with chronic headache. As documented by Termine, C.,
      Ferrari, Ginevra, O., D'Arrigo, S., Rossi, M., &amp; Lanzi, G. (2005), parents are often
      uncertain and fearful of submitting their children to treatment with traditional drugs,
      adolescents can use alternative therapies as a way of affirming their independence, and there
      are fewer drugs available to treat headache in children. Moreover, there is a 30-40% placebo
      response in headache sufferers (Mauskop, 2001). Children and adolescents should not be
      prevented from using alternative treatments, specifically essential oils, provided that the
      intervention is not harmful or costly. It is hoped this study will contribute to the scant
      research that exists and help define the indications, effects and limitations of aromatherapy
      use.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 25, 2015</start_date>
  <completion_date type="Actual">January 4, 2017</completion_date>
  <primary_completion_date type="Actual">January 4, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>improvement in subjective and objective indicators of discomfort</measure>
    <time_frame>30 minutes</time_frame>
    <description>pain and anxiety measured subjectively via VAS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>improvement in subjective and objective indicators of discomfort</measure>
    <time_frame>30 minutes</time_frame>
    <description>heart rate variability measured -10, 10 and 20 minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of Adverse Events</measure>
    <time_frame>30 minutes</time_frame>
    <description>assessment of presence or absence of Adverse Events or Serious Adverse Events</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Chronic Headache</condition>
  <condition>Migraine Headache</condition>
  <condition>Headache</condition>
  <arm_group>
    <arm_group_label>foot bath only</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>10 minute foot bath with addition of jojoba only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>foot bath and aromatherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 minute foot bath with addition of jojoba with added Mentha piperita</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>aromatherapy</intervention_name>
    <arm_group_label>foot bath and aromatherapy</arm_group_label>
    <other_name>Mentha piperita</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>foot bath</intervention_name>
    <arm_group_label>foot bath only</arm_group_label>
    <arm_group_label>foot bath and aromatherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • Male or female, children and adolescents age 7-17 years of age

               -  Diagnosed with status migrainosus or refractory chronic daily headache according
                  to the International Headache Society (ICHD-II) criteria. (A debilitating
                  migraine lasting for more than 72 hours or a headache that lasts hours or may be
                  continuous occurring on &gt; 15 days per month for &gt; 3 months.)

               -  No prior history of aromatherapy / essential oil use

               -  Able to read, comprehend and complete study procedures. Capable of reading and
                  completing all subjective measures in English

               -  Are sufficiently alert to be assessed and communicate

               -  Must be compliant with routine medical care and able to perform study-related
                  procedures

               -  Provide written informed consent from parent/legal guardian and child assent in
                  accordance with IRB regulations

        Exclusion Criteria:

          -  • Known sensitivity to essential oils

               -  History of cardiac fibrillation

               -  History of G6PD deficiency

               -  History of uncontrolled asthma (current, active wheezing)

               -  History of diabetes, high blood pressure, epilepsy,

               -  Inflammatory or sensory limitations of lower extremities or concurrent lesions of
                  the foot(s)

               -  Past or concurrent history of olfactory impairment

               -  Concomitant use of propanolol

               -  Tobacco use

               -  Hepatotoxicity

               -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rae A Kingsley, MSN, APRN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Mercy Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.heartmath.com</url>
    <description>developing and delivering research-based, practical, and reliable tools and technologies</description>
  </link>
  <link>
    <url>http://ihs-classification.org/en/</url>
    <description>headache classification</description>
  </link>
  <link>
    <url>http://www.cancer.gov/cancertopics/pdq/cam/aromatherapy/healthprofessional/</url>
    <description>Aromatherapy and Essential Oils (PDQ). National Cancer Institute at the National Institutes of Health</description>
  </link>
  <link>
    <url>http://www.naturalstandard.com</url>
    <description>Peppermint oil (Mentha x piperita L.). Natural Standard Database Web site.</description>
  </link>
  <link>
    <url>http://www.randomizer.org/</url>
    <description>Research Randomizer ©1997-2008 by Geoffery C. Urbaniak and Scott Plous Social Psychology Network</description>
  </link>
  <reference>
    <citation>Battaiglia, S. (2003). The complete guide to aromatherapy (2nd edition). Brisbane, Australia: The International Centre of Holistic Aromatherapy</citation>
  </reference>
  <reference>
    <citation>Blume HK. Pediatric headache: a review. Pediatr Rev. 2012 Dec;33(12):562-76. doi: 10.1542/pir.33-12-562. Review.</citation>
    <PMID>23204398</PMID>
  </reference>
  <reference>
    <citation>Buckle J. Use of aromatherapy as a complementary treatment for chronic pain. Altern Ther Health Med. 1999 Sep;5(5):42-51. Review.</citation>
    <PMID>10484830</PMID>
  </reference>
  <reference>
    <citation>Fitzgerald M, Culbert T, Finkelstein M, Green M, Liu M. The effect of gender and ethnicity on children's attitudes and preferences for essential oils: a follow up study. Explore (NY). 2010 May-Jun;6(3):172. doi: 10.1016/j.explore.2010.02.002.</citation>
    <PMID>20451151</PMID>
  </reference>
  <reference>
    <citation>Gardiner P, Wornham W. Recent review of complementary and alternative medicine used by adolescents. Curr Opin Pediatr. 2000 Aug;12(4):298-302. Review.</citation>
    <PMID>10943807</PMID>
  </reference>
  <reference>
    <citation>Gaul C, Eismann R, Schmidt T, May A, Leinisch E, Wieser T, Evers S, Henkel K, Franz G, Zierz S. Use of complementary and alternative medicine in patients suffering from primary headache disorders. Cephalalgia. 2009 Oct;29(10):1069-78. doi: 10.1111/j.1468-2982.2009.01841.x. Epub 2009 Apr 2.</citation>
    <PMID>19366356</PMID>
  </reference>
  <reference>
    <citation>Göbel H, Schmidt G, Soyka D. Effect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters. Cephalalgia. 1994 Jun;14(3):228-34; discussion 182.</citation>
    <PMID>7954745</PMID>
  </reference>
  <reference>
    <citation>Halcón LL. Aromatherapy: therapeutic applications of plant essential oils. Minn Med. 2002 Nov;85(11):42-6.</citation>
    <PMID>12498066</PMID>
  </reference>
  <reference>
    <citation>Kabbouche MA, Linder SL. Acute treatment of pediatric headache in the emergency department and inpatient settings. Pediatr Ann. 2005 Jun;34(6):466-71. Review.</citation>
    <PMID>16018229</PMID>
  </reference>
  <reference>
    <citation>Keifer D, Ulbricht C, Abrams TR, Basch E, Giese N, Giles M, DeFranco Kirkwood C, Miranda M, Woods J. Peppermint (Mentha piperita): an evidence-based systematic review by the Natural Standard Research Collaboration. J Herb Pharmacother. 2007;7(2):91-143. Review.</citation>
    <PMID>18285310</PMID>
  </reference>
  <reference>
    <citation>Kligler B, Chaudhary S. Peppermint oil. Am Fam Physician. 2007 Apr 1;75(7):1027-30. Review.</citation>
    <PMID>17427617</PMID>
  </reference>
  <reference>
    <citation>Lee MS, Choi J, Posadzki P, Ernst E. Aromatherapy for health care: an overview of systematic reviews. Maturitas. 2012 Mar;71(3):257-60. doi: 10.1016/j.maturitas.2011.12.018. Epub 2012 Jan 27. Review.</citation>
    <PMID>22285469</PMID>
  </reference>
  <reference>
    <citation>Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S; American Academy of Neurology Quality Standards Subcommittee; Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004 Dec 28;63(12):2215-24. Review.</citation>
    <PMID>15623677</PMID>
  </reference>
  <reference>
    <citation>Loman DG. The use of complementary and alternative health care practices among children. J Pediatr Health Care. 2003 Mar-Apr;17(2):58-63.</citation>
    <PMID>12665727</PMID>
  </reference>
  <reference>
    <citation>Martin, I. (2007). Aromatherapy for Massage Practitioners. Lippincott Williams Wilkins; Baltimore, MD.</citation>
  </reference>
  <reference>
    <citation>Mauskop A. Alternative therapies in headache. Is there a role? Med Clin North Am. 2001 Jul;85(4):1077-84. Review.</citation>
    <PMID>11480259</PMID>
  </reference>
  <reference>
    <citation>Mosby Skills Adapted from Perry, A.G., Potter, P.A., Ostendorf, W.R. (2014). Clinical nursing skills &amp; techniques (8th ed.). St. Louis: Mosby</citation>
  </reference>
  <reference>
    <citation>Nishimura M, Tatsuya Saito TS, Kato T, Onodera S. Effects of Water Temperature during Foot Bath in Young Females. Yonago Acta Med. 2013 Sep;56(3):79-80. Epub 2013 Sep 11.</citation>
    <PMID>24174706</PMID>
  </reference>
  <reference>
    <citation>Peterson CC, Palermo TM. Parental reinforcement of recurrent pain: the moderating impact of child depression and anxiety on functional disability. J Pediatr Psychol. 2004 Jul-Aug;29(5):331-41.</citation>
    <PMID>15187172</PMID>
  </reference>
  <reference>
    <citation>Posadzki P, Alotaibi A, Ernst E. Adverse effects of aromatherapy: a systematic review of case reports and case series. Int J Risk Saf Med. 2012 Jan 1;24(3):147-61. doi: 10.3233/JRS-2012-0568. Review.</citation>
    <PMID>22936057</PMID>
  </reference>
  <reference>
    <citation>Roth-Isigkeit A, Thyen U, Stöven H, Schwarzenberger J, Schmucker P. Pain among children and adolescents: restrictions in daily living and triggering factors. Pediatrics. 2005 Feb;115(2):e152-62. Erratum in: Pediatrics. 2005 Apr;115(4):1118.</citation>
    <PMID>15687423</PMID>
  </reference>
  <reference>
    <citation>Saeki Y. The effect of foot-bath with or without the essential oil of lavender on the autonomic nervous system: a randomized trial. Complement Ther Med. 2000 Mar;8(1):2-7.</citation>
    <PMID>10812753</PMID>
  </reference>
  <reference>
    <citation>Saeki Y, Nagai N, Hishinuma M. Effects of footbathing on autonomic nerve and immune function. Complement Ther Clin Pract. 2007 Aug;13(3):158-65. Epub 2007 Feb 20.</citation>
    <PMID>17631258</PMID>
  </reference>
  <reference>
    <citation>Schetzek S, Heinen F, Kruse S, Borggraefe I, Bonfert M, Gaul C, Gottschling S, Ebinger F. Headache in children: update on complementary treatments. Neuropediatrics. 2013 Feb;44(1):25-33. doi: 10.1055/s-0032-1333435. Epub 2013 Jan 11. Review.</citation>
    <PMID>23315555</PMID>
  </reference>
  <reference>
    <citation>Smith MC, Kyle L. Holistic foundations of aromatherapy for nursing. Holist Nurs Pract. 2008 Jan-Feb;22(1):3-9; quiz 10-1. doi: 10.1097/01.HNP.0000306321.03590.32. Review.</citation>
    <PMID>18172401</PMID>
  </reference>
  <reference>
    <citation>Stankewitz A, May A. Increased limbic and brainstem activity during migraine attacks following olfactory stimulation. Neurology. 2011 Aug 2;77(5):476-82. doi: 10.1212/WNL.0b013e318227e4a8. Epub 2011 Jul 20.</citation>
    <PMID>21775739</PMID>
  </reference>
  <reference>
    <citation>Szema AM, Barnett T. Allergic reaction to mint leads to asthma. Allergy Rhinol (Providence). 2011 Jan;2(1):43-5. doi: 10.2500/ar.2011.2.0008.</citation>
    <PMID>22852115</PMID>
  </reference>
  <reference>
    <citation>Termine C, Ginevra OF, D'Arrigo S, Rossi M, Lanzi G. Alternative therapies in the treatment of headache in childhood, adolescence and adulthood. Funct Neurol. 2005 Jan-Mar;20(1):9-14. Review.</citation>
    <PMID>15948561</PMID>
  </reference>
  <reference>
    <citation>Tisserand, R. &amp; Balacs, T. (1995). Essential oil safety. Edinburgh: Churchill Livingstone</citation>
  </reference>
  <reference>
    <citation>Tisserand, R. &amp; Young, R. (2014). Essential Oil Safety. A Guide for Health Care Professionals (2nd edition). Elsevier</citation>
  </reference>
  <reference>
    <citation>von Baeyer CL. Interpreting the high prevalence of pediatric chronic pain revealed in community surveys. Pain. 2011 Dec;152(12):2683-4. doi: 10.1016/j.pain.2011.08.023. Epub 2011 Sep 14.</citation>
    <PMID>21920669</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2015</study_first_submitted>
  <study_first_submitted_qc>May 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2015</study_first_posted>
  <last_update_submitted>April 7, 2017</last_update_submitted>
  <last_update_submitted_qc>April 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aromatherapy, peppermint</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Headache Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

